Nektar Therapeutics (NKTR) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025)
Nektar Therapeutics (NKTR) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39.61% |
| Sep 30, 2025 | -21.57% |
| Jun 30, 2025 | -80.33% |
| Mar 31, 2025 | -81.91% |
| Dec 31, 2024 | -81.91% |
| Sep 30, 2024 | -81.94% |
| Jun 30, 2024 | -32.66% |
| Mar 31, 2024 | -35.48% |
| Dec 31, 2023 | -41.89% |
| Sep 30, 2023 | -45.80% |
| Jun 30, 2023 | -43.32% |
| Mar 31, 2023 | -55.59% |
| Dec 31, 2022 | -46.37% |
| Sep 30, 2022 | -37.44% |
| Jun 30, 2022 | -32.09% |
| Mar 31, 2022 | 4.22% |
| Dec 31, 2021 | 1.42% |
| Sep 30, 2021 | -2.26% |
| Jun 30, 2021 | -4.52% |
| Mar 31, 2021 | -6.09% |